Lemercier Jean-Luc M
SEC CIK 1710625 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EW | Edwards Lifesciences | CVP, EMEACLA, JAPAC | 184.7K | — | $9.33M | 35 | 2021-11-29 | 2024-07-07 |
Most active insiders at EW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| 2 | Zovighian Bernard J | CEO, Dir | — | $7.00M |
| 3 | Ullem Scott B. | CFO, CVP | — | $3.87M |
| 4 | Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| 5 | Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| 6 | Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| 7 | Bruls Annette | CVP, EMEACLA | — | $237.9K |
| 8 | STONE HEISZ LESLIE | Dir | — | $218.1K |
| 9 | Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| 10 | Davis Leslie C. | Dir | — | — |
Lemercier Jean-Luc M made no open-market trades at EW in the last 12 months.
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-08 | 2024-07-07 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $92.32 | -82 | 184.7K | -0.0% | -$7,570 | |
| 2024-05-13 | 2024-05-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $86.72 | -21 | 184.8K | -0.0% | -$1,821 | |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $85.09 | -46 | 184.8K | -0.0% | -$3,914 |
| D | 2024-05-09 | 2024-05-07 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | A - Grant | $0.00 | +7,125 | 184.8K | +4% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $85.23 | -296 | 173.8K | -0.2% | -$25.2K |
| D | 2024-05-06 | 2024-05-04 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $0.00 | +4,157 | 178.0K | +2% | $0 |
| D | 2024-05-01 | 2024-05-01 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $36.75 | +14.4K | 188.2K | +8% | +$529.2K |
| DM | 2024-05-01 | 2024-05-01 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $84.22 | -14.4K | 186.1K | -7% | -$1.21M |
| D | 2024-04-08 | 2024-04-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA | M - OptEx | $36.75 | +14.4K | 188.2K | +8% | +$529.2K |
| DM | 2024-04-08 | 2024-04-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA | S - Sale+OE | $92.32 | -14.4K | 188.1K | -7% | -$1.33M |
| D | 2024-03-11 | 2024-03-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $36.75 | +14.4K | 188.0K | +8% | +$529.2K |
| D | 2024-03-11 | 2024-03-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $91.68 | -14.4K | 173.6K | -8% | -$1.32M |
| 2023-07-07 | 2023-07-07 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $90.46 | -81 | 173.6K | -0.0% | -$7,327 | |
| D | 2023-05-15 | 2023-05-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | A - Grant | $0.00 | +1,575 | 173.7K | +0.9% | $0 |
| DM | 2023-05-09 | 2023-05-07+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $88.74 | -328 | 172.2K | -0.2% | -$29.1K |
| DM | 2023-05-09 | 2023-05-07+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $23.38 | +9,995 | 172.4K | +6% | +$233.7K |
| D | 2023-05-09 | 2023-05-09 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $88.68 | -6,640 | 172.1K | -4% | -$588.8K |
| M | 2023-05-04 | 2023-05-03+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $87.96 | -75 | 169.1K | -0.0% | -$6,597 |
| D | 2023-04-06 | 2023-04-06 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $35.20 | +6,640 | 175.8K | +4% | +$233.7K |
| D | 2023-04-06 | 2023-04-06 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $83.10 | -6,640 | 169.1K | -4% | -$551.8K |
| DM | 2023-03-08 | 2023-03-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $76.95 | -6,640 | 168.9K | -4% | -$511.0K |
| D | 2023-03-08 | 2023-03-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $35.20 | +6,640 | 175.5K | +4% | +$233.7K |
| D | 2022-07-11 | 2022-07-07 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | A - Grant | $0.00 | +6,100 | 168.9K | +4% | $0 |
| 2022-05-17 | 2022-05-17 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | F - Tax | $95.93 | -143 | 162.8K | -0.1% | -$13.7K | |
| DM | 2022-05-10 | 2022-05-07+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | F - Tax | $100.52 | -666 | 155.0K | -0.4% | -$66.9K |
| DM | 2022-05-10 | 2022-05-08+ | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $12.52 | +20.1K | 163.5K | +14% | +$251.5K |
| D | 2022-05-10 | 2022-05-09 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $98.24 | -11.6K | 162.9K | -7% | -$1.14M |
| D | 2022-05-05 | 2022-05-03 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | A - Grant | $0.00 | +2,750 | 155.1K | +2% | $0 |
| D | 2022-05-05 | 2022-05-04 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | F - Tax | $105.93 | -42 | 155.0K | -0.0% | -$4,449 |
| D | 2022-04-11 | 2022-04-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +11.7K | 164.0K | +8% | +$253.7K |
| DM | 2022-04-11 | 2022-04-08 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $123.29 | -11.7K | 163.9K | -7% | -$1.44M |
| DM | 2022-03-11 | 2022-03-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $106.01 | -11.7K | 158.6K | -7% | -$1.24M |
| D | 2022-03-11 | 2022-03-11 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +11.7K | 163.8K | +8% | +$253.7K |
| D | 2021-11-29 | 2021-11-29 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $110.58 | -100 | 152.1K | -0.1% | -$11.1K |
| D | 2021-11-29 | 2021-11-29 | EW | Edwards Lifesciences | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +100 | 152.2K | +0.1% | +$2,176 |
Purchase Sale Sale after option exercise All abbreviations